Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cantor Fitzgerald
Federal Trade Commission
Merck
Express Scripts
McKesson
Deloitte
UBS
Fish and Richardson
Chinese Patent Office

Generated: June 19, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 060517

« Back to Dashboard

NDA 060517 describes FUNGIZONE, which is a drug marketed by Apothecon and Bristol Myers Squibb and is included in five NDAs. Additional details are available on the FUNGIZONE profile page.

The generic ingredient in FUNGIZONE is amphotericin b. There are fifteen drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the amphotericin b profile page.
Summary for 060517
Tradename:FUNGIZONE
Applicant:Apothecon
Ingredient:amphotericin b
Patents:0
Formulation / Manufacturing:see details
Medical Subject Heading (MeSH) Categories for 060517

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:INJECTABLE;INJECTIONStrength50MG/VIAL
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Baxter
Merck
Fish and Richardson
AstraZeneca
Teva
Moodys
Colorcon
Queensland Health
Accenture

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.